Golimumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Golimumab and local guidelines before prescribing.
Biologic (anti-TNF)
Mechanism
Anti-TNF monoclonal antibody.
Uses
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Infections, injection-site reactions, TB reactivation.
Interactions
Live vaccines contraindicated.
Contraindications and cautions
Active infection, heart failure
Monitoring
TB screen
Pregnancy and breastfeeding
Limited data
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
TB screening before starting.
More from the textbook: uses, cautions and other points
- TNF-alpha | Adalimumab, etanercept, infliximab, certolizumab, golimumab | RA, axial SpA, PsA, IBD, uveitis | TB reactivation , serious infections, avoid in moderate–severe heart failure and demyelinating disease , drug-induced lupus, skin cancers
Rheumatology: assessment, investigations and drugs - Infliximab (IV), adalimumab (SC), golimumab (UC) | TNF-alpha | Moderate to severe Crohn's and UC, perianal fistulas; TB reactivation , serious infections, worsens heart failure, demyelination, drug-induced lupus, paradoxical psoriasis, lymphoma (especially with thiopurines); infusion reactions; antibody formation - check drug levels and …
Gastroenterology: Anatomy Physiology Pharmacology - TNF | Adalimumab, etanercept, infliximab, certolizumab, golimumab | RA, psoriatic arthritis, axial SpA, uveitis
Rheumatology Anatomy Physiology Pharmacology - Anti-TNF (adalimumab, etanercept, certolizumab, golimumab, infliximab) - also helpful for uveitis (monoclonal antibodies, not etanercept) and IBD.
Rheumatology: Inflammatory arthritis - Drugs - infliximab (IV - chimeric), adalimumab , etanercept (receptor fusion - not effective in IBD), certolizumab pegol (minimal placental transfer), golimumab.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology - Uses - rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, Crohn's disease and ulcerative colitis (infliximab, adalimumab, golimumab), psoriasis, hidradenitis suppurativa, uveitis, sarcoidosis (refractory), Behçet's.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Inflammatory arthritis (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (2 mentions)